戻る Agenda
Unique Nonprofit-Industry Partnerships to Develop and Disseminate Technology
Session Chair(s)
Badri Rengarajan, MD
Life Sciences
Jazz Pharmaceuticals, United States
There are several barriers to developing and disseminating technology, including small scale of producer, lack of complete patient population data, and unfavorable economics/governance. Nonprofit-industry partnerships can help overcome these barriers. This session will present three examples highlighting unique aspects of the collaborations: A foundation’s $16 million funding effort to disseminate technology for simulating virtual patient populations, the Merck- Regenstrief Institute partnership and the co-development and dissemination of technology to support real-world evidence-based research and health care innovation, and a university’s direct investment in creating its own startups.
Learning Objective : Describe the importance and challenges of developing and disseminating new technologies and tools to health care providers and decision-makers; Discuss a unique partnership between nonprofit organizations and industry to develop and/or disseminate new technologies.
Speaker(s)
Unique Foundation-Industry Partnership to Disseminate Novel Virtual Population Simulation Technology
Brian Quinn, PHD
Robert Wood Johnson Foundation, United States
Team Director and Senior Program Officer
Merck-Regenstrief Partnership: An Academic-Pharmaceutical Company Partnership
Patrick Loerch, PHD
Gilead Sciences, Inc., United States
Senior Vice President, Clinical Data Science
A University's Direct Investment in Creating Its Own Startups
Ralph Lin, PHD
SNBL Ltd., United States
Global Strategy and Corporate Development Officer